501 related articles for article (PubMed ID: 27876436)
1. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
2. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery.
Zhan C; Lu W
Curr Pharm Biotechnol; 2012 Sep; 13(12):2380-7. PubMed ID: 23016643
[TBL] [Abstract][Full Text] [Related]
3. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
4. LDL receptors and their role in targeted therapy for glioma: a review.
Pawar S; Koneru T; McCord E; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 May; 26(5):1212-1225. PubMed ID: 33609780
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
Wang Z; Sun H; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 Aug; 26(8):1944-1952. PubMed ID: 33865978
[TBL] [Abstract][Full Text] [Related]
8. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery strategies for the treatment of malignant gliomas.
Allhenn D; Boushehri MA; Lamprecht A
Int J Pharm; 2012 Oct; 436(1-2):299-310. PubMed ID: 22721856
[TBL] [Abstract][Full Text] [Related]
10. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
11. Image-guided chemotherapy with specifically tuned blood brain barrier permeability in glioma margins.
Gao X; Yue Q; Liu Y; Fan D; Fan K; Li S; Qian J; Han L; Fang F; Xu F; Geng D; Chen L; Zhou X; Mao Y; Li C
Theranostics; 2018; 8(11):3126-3137. PubMed ID: 29896307
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles.
Lam FC; Morton SW; Wyckoff J; Vu Han TL; Hwang MK; Maffa A; Balkanska-Sinclair E; Yaffe MB; Floyd SR; Hammond PT
Nat Commun; 2018 May; 9(1):1991. PubMed ID: 29777137
[TBL] [Abstract][Full Text] [Related]
13. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
14. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
15. Local strategies and delivery systems for the treatment of malignant gliomas.
Yu F; Asghar S; Zhang M; Zhang J; Ping Q; Xiao Y
J Drug Target; 2019 Apr; 27(4):367-378. PubMed ID: 30101621
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
Zhang F; Xu CL; Liu CM
Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
[TBL] [Abstract][Full Text] [Related]
17. Endovascular therapies for malignant gliomas: Challenges and the future.
Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O
J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
19. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-based cerebral drug-delivery systems and antiangiogenic approach in gliomas treatment.
Raudino G; Caffo M; Caruso G; Alafaci C; Tomasello F
Recent Pat Nanotechnol; 2011 Nov; 5(3):239-44. PubMed ID: 21871014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]